Adulfo, Cheryl B.
HRN: 20-49-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2022
AMPICILLIN 1GM (VIAL)
09/01/2022
09/07/2022
IVTT
2g
Q6H
IUFD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes